Health Inspection requests patients to control their medicine Losartankalium of Apotex. Certain batch are contaminated

Dit item is gearchiveerd op 25-04-2019.

ORANJESTAD - The Inspection for Healthcare in Aruba (IVA) has recently received notification regarding a certain batch of Losartankalium of the pharmaceutical corporation Apotex that may have been contaminated with N-Nitroso-N-methyl-4-aminobutyric acid (NMBA).

Pill bottleLosartan potassium is prescribed to individuals who suffer from hight blood pressure and certain cardiac conditions. The IVA and pharmacies are requesting Losartan Potassium users to verify their medication and to immediately return contaminated pills to their pharmacies.

Drug inspector drs. Roselynn Angela (Pharmacist) is urging all users to check the batch number of their medications. In case you have a matching batch number, please return this immediately to your pharmacy and they will provide more information. According to the Drug Inspector, they are aware that many patients have questions and are worried, but she urges patients not to stop taking their medication. Consult your pharmacy for more information. The IVA will issue updates if necessary.

To verify the batch number of your Apotex Losartan Potassium, please consult attached list supplied by the manufacturing company.